Fluid-Screen is a biotech company that provides chip technology for bacterial capture.
Fluid-Screen microchip technology provides information about bacteria present in fluid samples in minutes instead of days. They help their partners, the pharmaceutical companies, accelerate the development and manufacturing of new therapeutics. Fluid-Screen provides real-time detection and identification of bacterial contamination in a variety of industries, including biotherapeutics manufacturing, healthcare, and water quality monitoring. By eliminating the time delays associated with traditional methods, the Fluid-Screen platform enables responsive, proactive decision-making when product, patient, and customer safety is jeopardized.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 31, 2022 | Series A | $1.16M | — | — | — | Detail |
May 30, 2021 | Series A | $1.54M | — | — | — | Detail |
Jun 20, 2019 | Series A | $5.30M | — | — | — | Detail |
Mar 10, 2017 | Series A | $1.99M | — | — | — | Detail |
Mar 11, 2015 | Grant | $150K | 1 | Massachusetts Clean Energy Center | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Massachusetts Clean Energy Center | Yes | Grant |
MassChallenge | — | Grant |